21 Feb 2024 Rejuvenate Biomed’s clinical trial demonstrates the therapeutic potential of RJx-01 in sarcopenia Member news
20 Feb 2024 argenx announces FDA acceptance of supplemental Biologics License Application with priority review for VYVGART Hytrulo in chronic inflammatory demyelinating polyneuropathy Member news
09 Feb 2024 VUB professor discovers genetic cause of low birth weight among children conceived after fertility treatment Member news
08 Feb 2024 Biotalys enters into academic collaborations with key scientific leaders in Europe and U.S. Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us